Skip to content


Somavert (pegvisomant) is a protein pharmaceutical. Pegvisomant was first approved as Somavert on 2002-11-12. It is used to treat acromegaly in the USA. It has been approved in Europe to treat acromegaly. The pharmaceutical is active against growth hormone receptor.
Trade Name Somavert
Common Name Pegvisomant
Indication acromegaly
Drug Class Pegylated compounds
Get full access now